Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.14M Buy
91,200
+13,200
+17% +$879K 0.08% 139
2026
Q1
$4.9M Buy
+78,000
New +$5.43M 0.07% 162
2022
Q2
Sell
-3,644
Closed -$466K 486
2022
Q1
$466K Buy
3,644
+1,168
+47% +$128K 0.02% 243
2021
Q4
$332K Buy
+2,476
New +$356K 0.02% 229

Other funds holding DXCM

AIA Group's DXCM Position: Q2 2026 in Review

AIA Group increased its DexCom (DXCM) stake by 17% in Q2 2026, buying an estimated $879K and bringing the position to 91,200 shares worth $6.14M. The position accounts for 0.08% of the portfolio, ranked #139.

AIA Group first reported a position in DXCM in Q4 2021 and has held it in 4 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • AIA Group held 91,200 shares of DexCom worth $6.14M as of Q2 2026.
  • AIA Group bought 13,200 DexCom shares in Q2 2026, an estimated $879K.
  • DexCom made up 0.08% of AIA Group's portfolio in Q2 2026, its #139 holding.
  • AIA Group first reported a position in DexCom in Q4 2021 and has held it in 4 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.